A pan-cancer analysis of IGF2BP2 mRNA expression derived from GEPIA2 revealed significantly increased expression in 13 tumor types relative to normal tissues and decreased expression in three tumor types [81]. The gene discussed is IGF2BP2; the disease is cancer.